Navigation Links
Fighting fungal infections with bacteria
Date:4/30/2010

A bacterial pathogen can communicate with yeast to block the development of drug-resistant yeast infections, say Irish scientists writing in the May issue of Microbiology. The research could be a step towards new strategies to prevent hospital-acquired infections associated with medical implants.

Researchers from University College Cork in Ireland studied the interaction between the bacterium Pseudomonas aeruginosa, which is often associated with severe burns, and the yeast Candida albicans, which can grow on plastic surfaces such as catheters. Both microbes are very common and although they are normally harmless to healthy individuals, they can cause disease in immunocompromised people.

The team discovered that molecules produced by P. aeruginosa bacteria were able to hinder the development of C. albicans 'biofilms' on silicone, when the yeast cells clump together on the surface of the plastic. Interestingly, the interaction between the two organisms did not depend on the well-studied bacterial communication system called Quorum Sensing, indicating that a novel signalling mechanism was at play.

C. albicans is the most common hospital-acquired fungal infection and can cause illness by sticking to and colonising plastic surfaces implanted in the body such as catheters, cardiac devices or prosthetic joints. This biofilm formation is a key aspect of C. albicans infection and is problematic as biofilms are often resistant to the antibiotics used to treat them. Dr John Morrissey, who led the team of researchers, said, "Candida albicans can cause very serious deep infections in susceptible patients and it is often found in biofilm form. It is therefore important to understand the biofilm process and how it might be controlled."

Dr Morrissey believes his work may lead to significant clinical benefits. "If we can exploit the same inhibitory strategy that the bacterium P. aeruginosa uses, then we might be able to design drugs that can be used as antimicrobials to disperse yeast biofilms after they form, or as additives onto plastics to prevent biofilm formation on medical implants," he said. "The next steps are to identify the chemical that the bacterium produces and to find out what its target in the yeast is. We can then see whether this will be a feasible lead for the development of new drugs for clinical application."


'/>"/>

Contact: Laura Udakis
l.udakis@sgm.ac.uk
44-118-988-1843
Society for General Microbiology
Source:Eurekalert  

Related biology news :

1. Social habits of cells may hold key to fighting diseases
2. When it comes fighting to C. difficile, the Palme dOr goes to soap and warm water
3. Fighting the spread of food poisoning
4. Gold nanorods shed light on new approach to fighting cancer
5. UV light improving chances of fighting cancer
6. Researchers uncover key trigger for potent cancer-fighting marine product
7. Fighting pollution the poplar way: Trees to clean up Indiana site
8. Fighting Aussie yabbies dont forget a face -- new research by the University of Melbourne
9. Strengthening the tumor-fighting ability of T cells
10. FSU researcher using computers to hone cancer-fighting strategies
11. UCSB study finds physical strength, fighting ability revealed in human faces
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fighting fungal infections with bacteria
(Date:3/30/2017)... 30, 2017  On April 6-7, 2017, Sequencing.com will ... hackathon at Microsoft,s headquarters in ... focus on developing health and wellness apps that provide ... the Genome is the first hackathon for personal ... largest companies in the genomics, tech and health industries ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/24/2017)... 2017 The Controller General of Immigration from Maldives ... Algeen have received the prestigious international IAIR Award for the most ... Reading ... Maldives ... Abdulla Algeen (small picture on the right) have received the IAIR award ...
Breaking Biology News(10 mins):
(Date:6/14/2017)... ... June 14, 2017 , ... Cynvenio Biosystems, Inc. ... new distribution agreements for Cynvenio’s ClearID line of blood tests that support targeted treatment ... make ClearID available immediately in Israel, Greece, Argentina, and South Korea. , ...
(Date:6/14/2017)... ... June 14, 2017 , ... ... Phase 1 clinical study of AC0058, a novel irreversible Bruton’s Tyrosine Kinase ... autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. Fifty-six (56) ...
(Date:6/13/2017)... Philadelphia, PA (PRWEB) , ... June 13, 2017 ... ... from the University City Science Center’s Phase 1 Ventures (P1V) program. PolyCeramX, Recensa ... of technical development and commercialization activities. , Phase 1 Ventures is a ...
(Date:6/13/2017)... ... June 13, 2017 , ... Exxact ... research, today announced that it will offer the new NVIDIA® DGX Station™ and ... NVIDIA Volta™ architecture. , “NVIDIA’s DGX portfolio is paving the way for a ...
Breaking Biology Technology: